首页> 外文期刊>International journal of endocrinology >A Chinese Family with Familial Dysalbuminemic Hyperthyroxinemia (FDH) due to R242H Mutation on Human Albumin Gene: Reevaluating the Role of FDH in Patients with Asymptomatic Hyperthyroxinemia
【24h】

A Chinese Family with Familial Dysalbuminemic Hyperthyroxinemia (FDH) due to R242H Mutation on Human Albumin Gene: Reevaluating the Role of FDH in Patients with Asymptomatic Hyperthyroxinemia

机译:一种中国家庭,具有家族性脱氨磷酸甲亢(FDH)引起的人白蛋白基因R242H突变:重新评估FDH在无症状甲亢患者中的作用

获取原文
           

摘要

Objective. Familial dysalbuminemic hyperthyroxinemia (FDH) has now become an established cause for spurious asymptomatic hyperthyroxinemia. Several different codon mutations on albumin gene had been identified. We here provided an established but rarely reported heterozygous mutation based on gene sequencing results from a Chinese family. Methods. The proband is a 14-year-old girl with light goiter and asymptomatic clinical presentations, whose thyroid function test by a one-step immunoassay showed increased free thyroxine (FT4) and free triiodothyronine (FT3) but nonsuppressed thyrotropin (TSH). All thyroid auto-antibodies were in the normal range. Blood samples were collected from her and most of her immediate family members for target gene sequencing and verification. Results. Hyperthyroxinemia was also confirmed in the proband’s mother and one of her uncles and his son. In the proband and these three pedigrees, the high-throughput gene screening sequencing and the following Sanger sequencing disclosed a heterozygous mutation in the albumin gene, which located in its exon 7 (c.725G??A), and correspondingly leads to an arginine replacement with a histidine (R242H) in its protein. This is an established mutation named as R218H if present without signal peptide sequence. Conclusions. For patients with asymptomatic hyperthyroxinemia, FDH should be clinically excluded before embarking on further investigations for other specific causes.
机译:客观的。家族性脱氨磷酸甲亢(FDH)现在已成为杂散无症状甲亢的成熟原因。已经确定了几种不同的密码子突变已经鉴定了白蛋白基因。我们在这里提供了基于中国家庭基因测序结果的既定但很少报道的杂合突变。方法。该证书是一个14岁的女孩,具有轻微的甲状腺肿和无症状的临床介绍,其甲状腺功能测试通过一步免疫测定显示出增加的游离甲状腺素(FT4)和游离三碘甲蛋白(FT3),但是不卷积的甲状腺素(TSH)。所有甲状腺自动抗体都在正常范围内。从她的血液样本和大多数靶向基因测序和核查中收集血液样本。结果。甲状腺血症血症也在证据的母亲和她的一个叔叔和儿子中得到了证实。在证书和这三个章节中,高通量基因筛选测序和以下Sanger测序公开了白蛋白基因中的杂合突变,其位于其外显子7(C.725G ???A),并相应地导致一个用组氨酸(R242H)在其蛋白质中的精氨酸替代。如果没有信号肽序列存在,这是一个名为R218H的已建立的突变。结论。对于无症状甲状腺血症血症的患者,FDH应在开始进一步调查其他特定原因之前临床排除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号